CRISPR ethical dilemmas present a fascinating yet troubling frontier in the realm of gene editing ethics.As CRISPR technology continues to evolve, its ability to modify genetic material raises urgent questions about morality, responsibility, and equality in healthcare.
Gene editing breakthroughs are revolutionizing the landscape of medicine, transforming how we approach genetic diseases.Recent advancements, such as base editing and prime editing developed by researchers like David Liu, have opened new frontiers in the fight against conditions that were once deemed untreatable.